Immunomodulation by transplanted human embryonic stem cell-derived oligodendroglial progenitors in experimental autoimmune encephalomyelitis

Stem Cells

Volumn 30, Issue 12, 2012, Pages 2820-2829

  Kim, Heechul ^a   Walczak, Piotr ^a   Kerr, Candace ^a   Galpoththawela, Chulani ^a   Gilad, Assaf A ^a   Muja, Naser ^a   Bulte, Jeff W M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell tracking; Experimental autoimmune encephalomyelitis; Human embryonic stem cells; Immunomodulation; Oligodendrocyte progenitors

Indexed keywords

CHEMOKINE; CYTOKINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BRAIN; BRAIN VENTRICLE; CELL TRACKING; CONTROLLED STUDY; DISABILITY; EMBRYONIC STEM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MOUSE; MULTIPLE SCLEROSIS; NEURAL STEM CELL; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; REGULATORY T LYMPHOCYTE; SCORING SYSTEM; SPECTROMETER; SPINAL CORD; SPLEEN; STEM CELL TRANSPLANTATION; SUBARACHNOID SPACE; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; OLIGODENDROGLIA;

ANIMALIA; MUS;

EID: 84870371604     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1218     Document Type: Article

References (51)

1. Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002;3:291-301.
2. Hohlfeld R, Wekerle H. Drug insight: Using monoclonal antibodies to treat multiple sclerosis. Nat Clin Pract Neurol 2005;1:34-44.
3. Pluchino S, Zanotti L, Brini E et al. Regeneration and repair in multiple sclerosis: The role of cell transplantation. Neurosci Lett 2009;456:101-106.
4. Aharonowiz M, Einstein O, Fainstein N et al. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One 2008;3:e3145.
5. Ben-Hur T. Immunomodulation by neural stem cells. J Neurol Sci 2008;265:102-104.
6. Einstein O, Friedman-Levi Y, Grigoriadis N et al. Transplanted neural precursors enhance host brain-derived myelin regeneration. J Neurosci 2009;29:15694-15702.
7. Walczak P, All AH, Rumpal N et al. Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination. Glia 2011;59:499-510.
8. Windrem MS, Nunes MC, Rashbaum WK et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004;10:93-97.
9. Pluchino S, Zanotti L, Brambilla E et al. Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS One 2009;4:e5959.
10. Lu Z, Hu X, Zhu C et al. Overexpression of CNTF in mesenchymal stem cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. J Neuroimmunol 2009;206:58-69.
11. Makar TK, Bever CT, Singh IS et al. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J Neuroimmunol 2009;210:40-51.
12. Makar TK, Trisler D, Bever CT et al. Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis. J Neuroimmunol 2008;196:67-81.
13. Yang J, Jiang Z, Fitzgerald DC et al. Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis. J Clin Invest 2009;119:3678-3691.
14. Politi LS, Bacigaluppi M, Brambilla E et al. Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis. Stem Cells 2007;25:2583-2592.
15. Muja N, Cohen ME, Zhang J et al. Neural precursors exhibit distinctly different patterns of cell migration upon transplantation during either the acute or chronic phase of EAE: A serial MR imaging study. Magn Reson Med 2011;65:1738-1749.
16. Berman SC, Galpoththawela C, Gilad AA et al. Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med 2011;65:564-574.
17. Letzen BS, Liu C, Thakor NV et al. MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells. PLoS One 2010;5:e10480.
18. Reubinoff BE, Pera MF, Fong CY et al. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404.
19. Mareschi K, Novara M, Rustichelli D et al. Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types. Exp Hematol 2006;34:1563-1572.
20. Katkov II, Kim MS, Bajpai R et al. Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology 2006;53:194-205.
21. Hsieh CL, Koike M, Spusta SC et al. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 2009;109:1144-1156.
22. Neumann H, Kotter MR, Franklin RJ. Debris clearance by microglia: An essential link between degeneration and regeneration. Brain 2009;132:288-295.
23. Neumann H, Takahashi K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol 2007;184:92-99.
24. Piccio L, Buonsanti C, Mariani M et al. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2007;37:1290-1301.
25. Takahashi K, Prinz M, Stagi M et al. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 2007;4:e124.
26. Karussis D, Karageorgiou C, Vaknin-Dembinsky A et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010;67:1187-1194.
27. Korn T, Reddy J, Gao W et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007;13:423-431.
28. Mikita J, Dubourdieu-Cassagno N, Deloire MS et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 2011;17:2-15.
29. O'Connor RA, Anderton SM. Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol 2008;193:1-11.
30. Stephens LA, Malpass KH, Anderton SM. Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg. Eur J Immunol 2009;39:1108-1117.
31. Bonnamain V, Neveu I, Naveilhan P. In vitro analyses of the immuno-suppressive properties of neural stem/progenitor cells using anti-CD3/CD28-activated T cells. Methods Mol Biol 2011;677:233-243.
32. Zhang YW, Denham J, Thies RS. Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev 2006;15:943-952.
33. Sharp J, Frame J, Siegenthaler M et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 2010;28:152-163.
34. Zhang J, Li Y, Chen J et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005;195:16-26.
35. Pluchino S, Quattrini A, Brambilla E et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003;422:688-694.
36. Pluchino S, Zanotti L, Rossi B et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005;436:266-271.
37. Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol 2003;3:445-453.
38. Prada I, Ongania GN, Buonsanti C et al. Triggering receptor expressed in myeloid cells 2 (TREM2) trafficking in microglial cells: Continuous shuttling to and from the plasma membrane regulated by cell stimulation. Neuroscience 2006;140:1139-1148.
39. Piccio L, Buonsanti C, Cella M et al. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain 2008;131:3081-3091.
40. Chabas D, Baranzini SE, Mitchell D et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001;294:1731-1735.
41. Engelhardt B. Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines. J Neurol Sci 2008;274:23-26.
42. Ransohoff RM, Kivisakk P, Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003;3:569-581.
43. Shin T, Kojima T, Tanuma N et al. The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J Neuroimmunol 1995;56:171-178.
44. Toft-Hansen H, Fuchtbauer L, Owens T. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 2011;59:166-176.
45. Zhu YN, Zhong XG, Feng JQ et al. Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes. J Pharmacol Exp Ther 2006;318:1153-1162.
46. Muzio L, Cavasinni F, Marinaro C et al. Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis. Mol Cell Neurosci 2010;43:268-280.
47. Yong VW, Zabad RK, Agrawal S et al. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J Neurol Sci 2007;259:79-84.
48. Crocker SJ, Whitmire JK, Frausto RF et al. Persistent macrophage/ microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am J Pathol 2006;169:2104-2116.
49. Thorne M, Moore CS, Robertson GS. Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice. J Neuroimmunol 2009;211:92-100.
50. Moore CS, Milner R, Nishiyama A et al. Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci 2011;31:6247-6254.
51. Coyne TM, Marcus AJ, Woodbury D et al. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 2006;24:2483-2492.